共 9 条
[1]
Nocturnal acid breakthrough: clinical significance and correlation with esophageal acid exposure[J] . Tina M Ours,W.Keith Fackler,Joel E Richter,Michael F Vaezi.The American Journal of Gastroenterology . 2003 (3)
[3]
Step-down management of gastroesophageal reflux disease
[J].
GASTROENTEROLOGY,
2001, 121 (05)
:1095-1100
[4]
Efficacy and safety of esomeprazole compared with omeprazole in GERD patients with erosive esophagitis: a randomized controlled trial[J] . Joel E. Richter,Peter J. Kahrilas,John Johanson,Paul Maton,Jeffrey R. Breiter,Clara Hwang,Victoria Marino,Bernard Hamelin,Jeffrey G. Levine.The American Journal of Gastroenterology . 2001 (3)
[5]
Rabeprazole Versus Omeprazole in Preventing Relapse of Erosive or Ulcerative Gastroesophageal Reflux Disease[J] . Bjarni Thjodleifsson,Johannes A. Beker,Cornelius Dekkers,Tone Bjaaland,Victoria Finnegan,Thomas J. Humphries.Digestive Diseases and Sciences . 2000 (5)
[7]
High- versus standard-dose ranitidine for control of heartburn in poorly responsive acid reflux disease: a prospective, controlled trial[J] . Peter J Kahrilas,M.Brian Fennerty,Bo Joelsson.The American Journal of Gastroenterology . 1999 (1)
[8]
Symptomatic Gastro-Oesophageal Reflux Disease: Double Blind Controlled Study of Intermittent Treatment with Omeprazole or Ranitidine[J] . K. D. Bardhan,S. Müller-Lissner,M. A. Bigard,G. Bianchi Porro,J. Ponce,J. Hosie,Mairi Scott,D. G. Weir,K. R. W. Gillon,R. A. Peacock,Claire Fulton for the European Study Group.BMJ: British Medical Journal . 1999 (7182)